Filing Details

Accession Number:
0001415889-19-001311
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-15 10:49:39
Reporting Period:
2019-11-14
Accepted Time:
2019-11-15 10:49:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1386570 Chromadex Corp. CDXC Medicinal Chemicals & Botanical Products (2833) 262940963
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1417952 N Robert Fried 10900 Wilshire Blvd. Suite 600
Los Angeles CA 90024
Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-14 10,000 $3.09 1,444,315 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,746 Indirect See Footnote
Footnotes
  1. Previous Form 4's disclosing the Reporting Person's beneficial ownership inadvertently overstated the number of shares directly beneficially owned by the Reporting Person by 2,012 shares. The number of shares is corrected in this Form 4.
  2. 6,745 shares held by Jeremy Fried and 6,001 shares held by Benjamin Fried, who are both sons of Robert Fried. The number of shares reflected as indirectly beneficially owned reflects an additional two shares inadvertently omitted from the Reporting Person's prior Form 4's.